Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female, 18 years of age or older with an overall baseline Lip Fullness Scale (LFS) score of minimal, mild or moderate on the 5-point LFS scale.~* Has the ability to follow study instructions and is likely to complete all required visits~Exclusion Criteria:~* Has had any facial procedures or trauma that may interfere with the study procedures and results~* Is on anti-coagulation therapy or other contraindicated treatments~* Has current cutaneous inflammatory or infectious processes or lesions in the mouth area

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- JUVÉDERM® VOLBELLA® XC with Lidocaine (Type: EXPERIMENTAL): JUVÉDERM® VOLBELLA® XC with lidocaine injected into lips at Day 1. Participants were eligible to receive optional touch-up retreatment one month following initial treatment if applicable.
- No-treatment Control (Type: EXPERIMENTAL): No-treatment was administered during control period. After 3 months, participants were eligible to receive treatment with JUVÉDERM® VOLBELLA® XC with lidocaine if applicable followed by an optional touch-up retreatment one month following initial treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).